Stem cell-based therapy for COVID-19 and ARDS: a systematic review
Abstract Despite global efforts to establish effective interventions for coronavirus disease 2019 (COVID-19) and its major complications, such as acute respiratory distress syndrome (ARDS), the treatment remains mainly supportive. Hence, identifying an effective and safe therapy for severe COVID-19...
Guardado en:
Autores principales: | Gabriele Zanirati, Laura Provenzi, Lucas Lobraico Libermann, Sabrina Comin Bizotto, Isadora Machado Ghilardi, Daniel Rodrigo Marinowic, Ashok K. Shetty, Jaderson Costa Da Costa |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/be44813379604b6997d19051a1aa8d11 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Further validation of the efficacy of mesenchymal stem cell infusions for reducing mortality in COVID-19 patients with ARDS
por: Ashok K. Shetty, et al.
Publicado: (2021) -
Promises and challenges of personalized medicine to guide ARDS therapy
por: Katherine D. Wick, et al.
Publicado: (2021) -
¿Arde Bolivia?
Publicado: (2006) -
¿Arde París?
por: Collins, Larry, et al.
Publicado: (1997) -
AVDS should not dethrone ARDS
por: Yazine Mahjoub, et al.
Publicado: (2021)